Target intelligence / Profile preview

L-methionine gamma-lyase (MGL)

Target
MGL
Molecular classification
Enzyme, Carbon-sulfur lyase, Pyridoxal phosphate-dependent enzyme
01

Overview

Volatile sulfur compound-producing bacterial enzymes are a functional group of microbial enzymes, most notably L-methionine gamma-lyase (MGL) and cysteine desulfhydrase, that catalyze the degradation of sulfur-containing amino acids into malodorous gases. These enzymes are primarily expressed by anaerobic Gram-negative bacteria such as Porphyromonas gingivalis, Treponema denticola, and Fusobacterium nucleatum, which are common inhabitants of the oral cavity and the gastrointestinal tract. The primary metabolic products—hydrogen sulfide, methyl mercaptan, and dimethyl sulfide—are the main contributors to halitosis and have been implicated in the progression of periodontal disease by inducing inflammation and increasing tissue permeability. Therapeutic interventions often target these enzymes using metal ions like zinc, which both inhibit enzymatic activity and chemically neutralize the produced gases. Additionally, antimicrobial agents and probiotics are used to manage the bacterial populations responsible for enzyme production, while experimental inhibitors like propargylglycine are being explored for more precise enzymatic targeting.

Other names
Methionine gamma-lyaseMethioninaseL-methionine gamma-lyase-deaminaseMgldMEGLC-S lyaseVolatile sulfur compound-producing bacterial enzymes
02

Mechanism of action

Competitive inhibition of enzyme activity, direct enzymatic blockade, chemical neutralization of metabolic byproducts (VSCs), and reduction of bacterial populations expressing the enzymes.

03

Biological functions

Amino acid metabolismSulfur metabolismMethionine catabolismCysteine degradationVolatile sulfur compound production
04

Disease associations

HalitosisPeriodontitisGingivitisOral malodorInflammatory bowel disease
05

Safety considerations

Oral microbiome dysbiosisDysgeusia (taste alteration)Tooth staining (associated with chlorhexidine)Potential systemic toxicity of experimental inhibitors
06

Interacting drugs

Zinc chloride

9 more in the full profile.

07

Biomarkers

Breath hydrogen sulfide levelsBreath methyl mercaptan levelsBreath dimethyl sulfide levelsTongue coating scoreBANA test (N-benzoyl-DL-arginine-2-naphthylamide) for proteolytic activity

Beyond the preview

Go deeper on L-methionine gamma-lyase (MGL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-methionine gamma-lyase (MGL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call